Patent · US Active

Fusion proteins of GLP-1 and GDF15 and conjugates thereof

US11453711B2 · kind B2 · utility

0Cited by
53References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 6, 2021
Grant dateSep 27, 2022
Priority date
Expiry dateSep 6, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides fusion polypeptides comprising GLP-1 and GDF15, the polypeptide complexes, and the conjugates thereof. Pharmaceutical compositions comprising the same and methods of treating diseases are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.